Endothelin-1 (ET-1) is an autocrine/paracrine regulator of renal and vascular function, and antagonism of ET-1 effects has been pursued as a therapeutic target for cardiovascular diseases. The gene discussed is EDN1; the disease is cardiovascular disorder.